Wednesday, September 6, 2017

US FDA News: Kayexalate (sodium polystyrene sulfonate): Drug Safety Communication - FDA Recommends Separating Dosing

Too much potassium in the blood can cause problems with heart rhythm, which in rare cases can be fatal.
Read more: Kayexalate (sodium polystyrene sulfonate): Drug Safety Communication - FDA Recommends Separating Dosing